MoneyWorks4Me

The revenue for the March 2023 quarter is pegged at Rs. 19390.48 millions, about 8.60% up against Rs. 17855.44 millions recorded during the year-ago period.The Net Loss for the quarter ended March 2023 is Rs. -1374.69 millions as compared to Net Profit of Rs. 2055.97 millions of corresponding quarter ended March 2022Operating profit for the quarter ended March 2023 rose to 4506.36 millions as compared to 3405.67 millions of corresponding quarter ended March 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 19390.48 17855.44 8.60 82206.62 81415.81 0.97 82206.62 81415.81 0.97
Other Income 2329.65 1789.82 30.16 9859.39 6146.28 60.41 9859.39 6146.28 60.41
PBIDT 4506.36 3405.67 32.32 24587.06 23028.49 6.77 24587.06 23028.49 6.77
Interest 588.60 740.10 -20.47 2068.16 2360.41 -12.38 2068.16 2360.41 -12.38
PBDT -2665.96 2665.57 -200.01 17560.22 24971.41 -29.68 17560.22 24971.41 -29.68
Depreciation 467.29 417.72 11.87 1841.48 1596.95 15.31 1841.48 1596.95 15.31
PBT -3133.25 2247.85 -239.39 15718.74 23374.46 -32.75 15718.74 23374.46 -32.75
TAX -1758.56 191.88 -1016.49 3631.05 3396.57 6.90 3631.05 3396.57 6.90
Deferred Tax -2605.10 -210.77 1135.99 -238.26 -714.21 -66.64 -238.26 -714.21 -66.64
PAT -1374.69 2055.97 -166.86 12087.69 19977.89 -39.49 12087.69 19977.89 -39.49
Equity 282.17 282.17 0.00 282.17 282.17 0.00 282.17 282.17 0.00
PBIDTM(%) 23.24 19.07 21.84 29.91 28.29 5.74 29.91 28.29 5.74
Peers
Company Name CMP
Sun Pharma. Inds. 1783.25
Dr. Reddys Labs. 1202.40
Cipla 1329.50
Lupin 2007.10
Zydus Lifesciences 1154.00
View more..